By analysis, we found multiple tumor-related pathways were enriched, so we further examined the key effectors of these pathway upon depletion of JOSD2, and found that these cancer-associated pathways experienced varying degrees of upregulation or downregulation (Supplementary Fig. S3c). Here, JOSD2 is linked to neoplasm.